{"log_id": 1143170541294405170, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0, "average": 0.841759, "min": 0.841759}, "location": {"width": 61, "top": 140, "height": 21, "left": 691}, "words": " AUCO"}, {"probability": {"variance": 0, "average": 0.999685, "min": 0.999531}, "location": {"width": 47, "top": 163, "height": 26, "left": 342}, "words": "剂量"}, {"probability": {"variance": 0.029235, "average": 0.896627, "min": 0.600645}, "location": {"width": 55, "top": 159, "height": 25, "left": 818}, "words": " In(h)"}, {"probability": {"variance": 0.001343, "average": 0.970431, "min": 0.887028}, "location": {"width": 277, "top": 182, "height": 25, "left": 490}, "words": "ng/md)(h)(ngh/m)"}, {"probability": {"variance": 0.00081, "average": 0.987742, "min": 0.826752}, "location": {"width": 553, "top": 220, "height": 36, "left": 336}, "words": "250mg12656±3751.7±0.94222±22627.88±3.13"}, {"probability": {"variance": 0.004004, "average": 0.975007, "min": 0.654128}, "location": {"width": 438, "top": 264, "height": 32, "left": 337}, "words": "500mg121025±4222.3±1.08281±2628"}, {"probability": {"variance": 0.00307, "average": 0.973634, "min": 0.837978}, "location": {"width": 72, "top": 264, "height": 22, "left": 815}, "words": "03±3.92"}, {"probability": {"variance": 0.000905, "average": 0.985471, "min": 0.85894}, "location": {"width": 438, "top": 306, "height": 32, "left": 337}, "words": "750mg12785±3422.2±1.16414±2946"}, {"probability": {"variance": 0.002852, "average": 0.960017, "min": 0.852603}, "location": {"width": 68, "top": 306, "height": 21, "left": 816}, "words": "38±3.80"}, {"probability": {"variance": 5.5e-05, "average": 0.997377, "min": 0.94998}, "location": {"width": 952, "top": 348, "height": 45, "left": 157}, "words": "转移性实体瘤患者餐后单次空腹口服500mg,750mg和850mg后,吸收略有延迟,原形药"}, {"probability": {"variance": 0.002615, "average": 0.973145, "min": 0.789397}, "location": {"width": 992, "top": 403, "height": 46, "left": 117}, "words": "物血浆浓度平均达峰时间约为3.9~5.1h,平均消除半衰期为8.5~9.0h。在500mg和750mg剂"}, {"probability": {"variance": 1e-05, "average": 0.99774, "min": 0.98431}, "location": {"width": 994, "top": 457, "height": 48, "left": 118}, "words": "量组,原形药物血浆暴露量(AUC和Cmax)与剂量成正比例,但850mg剂量组原形药暴露量"}, {"probability": {"variance": 0, "average": 0.99967, "min": 0.997417}, "location": {"width": 629, "top": 518, "height": 39, "left": 117}, "words": "水平增加比例低于剂量增加比例。各药代动力学参数见表6"}, {"probability": {"variance": 0.000364, "average": 0.990373, "min": 0.899222}, "location": {"width": 865, "top": 569, "height": 42, "left": 157}, "words": "表6.转移性实体瘤患者单次空腹口服500mg、750mg和850mg阿帕替尼后的药代动力学分析"}, {"probability": {"variance": 0.066042, "average": 0.777138, "min": 0.370711}, "location": {"width": 250, "top": 621, "height": 67, "left": 268}, "words": "聚剂量nC"}, {"probability": {"variance": 0, "average": 0.986337, "min": 0.986337}, "location": {"width": 47, "top": 627, "height": 19, "left": 720}, "words": " AUC"}, {"probability": {"variance": 1.1e-05, "average": 0.994083, "min": 0.990782}, "location": {"width": 21, "top": 648, "height": 21, "left": 637}, "words": "(h"}, {"probability": {"variance": 0.015415, "average": 0.91053, "min": 0.734957}, "location": {"width": 52, "top": 644, "height": 22, "left": 854}, "words": " tu (h"}, {"probability": {"variance": 0.001077, "average": 0.963362, "min": 0.920357}, "location": {"width": 69, "top": 670, "height": 21, "left": 478}, "words": "ng/MD)"}, {"probability": {"variance": 0.006722, "average": 0.926758, "min": 0.816671}, "location": {"width": 86, "top": 665, "height": 23, "left": 714}, "words": " (ngh/md)"}, {"probability": {"variance": 0.002473, "average": 0.943458, "min": 0.860041}, "location": {"width": 155, "top": 709, "height": 37, "left": 280}, "words": "500mg12"}, {"probability": {"variance": 0.000913, "average": 0.989982, "min": 0.827977}, "location": {"width": 433, "top": 707, "height": 25, "left": 493}, "words": "0±6043.92±1.556226±41558.46±2.49"}, {"probability": {"variance": 0.008376, "average": 0.906299, "min": 0.676808}, "location": {"width": 355, "top": 746, "height": 36, "left": 315}, "words": "0mg1911225912.780.63"}, {"probability": {"variance": 0.000257, "average": 0.989303, "min": 0.93919}, "location": {"width": 217, "top": 747, "height": 27, "left": 712}, "words": "9895±55369.07±1.29"}, {"probability": {"variance": 0.000337, "average": 0.978014, "min": 0.959655}, "location": {"width": 18, "top": 800, "height": 20, "left": 306}, "words": "85"}, {"probability": {"variance": 0.002604, "average": 0.968505, "min": 0.833525}, "location": {"width": 250, "top": 791, "height": 27, "left": 468}, "words": "528±24685.11±3.4422"}, {"probability": {"variance": 0.015346, "average": 0.948286, "min": 0.526613}, "location": {"width": 146, "top": 790, "height": 20, "left": 778}, "words": "16888.99±2.06"}, {"probability": {"variance": 7.8e-05, "average": 0.995644, "min": 0.960921}, "location": {"width": 947, "top": 829, "height": 47, "left": 169}, "words": "在11例转移性实体肿瘤患者考察了750mg/日多次给药的药代动力学特征。结果表明在连续"}, {"probability": {"variance": 1.4e-05, "average": 0.997628, "min": 0.983259}, "location": {"width": 578, "top": 889, "height": 41, "left": 119}, "words": "给药期间(56天),受试者体内未发生药物蓄积现象"}, {"probability": {"variance": 1e-05, "average": 0.997911, "min": 0.986134}, "location": {"width": 921, "top": 938, "height": 45, "left": 170}, "words": "在转移性实体瘤患者(n=9,男性6名,女性3名)中考察了进食对阿帕替尼吸收的影响"}, {"probability": {"variance": 0.000145, "average": 0.995034, "min": 0.926015}, "location": {"width": 997, "top": 992, "height": 46, "left": 120}, "words": "对受试者餐前1h与餐后0.5h单次口服750mg/日吸收的差异进行比较。结果表明进食与服药顺"}, {"probability": {"variance": 0.00904, "average": 0.953223, "min": 0.62032}, "location": {"width": 480, "top": 1056, "height": 39, "left": 123}, "words": "序对Tmax、Cmax、AUC和t1n均无显著影响"}, {"probability": {"variance": 1.7e-05, "average": 0.997751, "min": 0.981651}, "location": {"width": 937, "top": 1100, "height": 47, "left": 173}, "words": "在转移性实体瘤患者单次口服给药的研究中观察到850mg剂量组不同性别受试者阿帕替"}, {"probability": {"variance": 0.000293, "average": 0.993215, "min": 0.896635}, "location": {"width": 981, "top": 1155, "height": 47, "left": 124}, "words": "尼及其代谢产物M1暴露水平(Cmax和AUC)存在统计学差异,其中女性AUC比男性的高1.96"}, {"probability": {"variance": 0.000595, "average": 0.991192, "min": 0.869368}, "location": {"width": 921, "top": 1209, "height": 47, "left": 124}, "words": "倍,Cmax高3.57倍。由于样本量较小(男性5例,女性4例),尚难对这种差别作出结论"}, {"probability": {"variance": 7e-06, "average": 0.998499, "min": 0.989424}, "location": {"width": 946, "top": 1263, "height": 46, "left": 175}, "words": "年龄、体重对阿帕替尼的药代动力学特征无显著影响,因此临床使用时不需根据上述因素"}, {"probability": {"variance": 0, "average": 0.999123, "min": 0.998018}, "location": {"width": 176, "top": 1330, "height": 35, "left": 126}, "words": "对剂量进行调整"}, {"probability": {"variance": 9e-06, "average": 0.998496, "min": 0.989469}, "location": {"width": 302, "top": 1380, "height": 39, "left": 174}, "words": "剂量水平与暴露水平相关性"}, {"probability": {"variance": 1.4e-05, "average": 0.99811, "min": 0.983423}, "location": {"width": 948, "top": 1428, "height": 45, "left": 174}, "words": "转移性实体瘤患者单次给药的药代动力学研究中,阿帕替尼的暴露水平随着口服给药剂量"}, {"probability": {"variance": 1.2e-05, "average": 0.998199, "min": 0.985965}, "location": {"width": 373, "top": 1493, "height": 40, "left": 129}, "words": "增加而增加,但不呈剂量比例关系"}], "language": 3}